Amid swirling speculation, Bausch + Lomb ($BLCO), a global leader in the contact lens supply industry, is reportedly ...

As a standalone public company, Bausch now has the ability to freely allocate financial resources to innovate and develop businesses that were underfunded under its former parent company. We believe ...

Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Bausch + Lomb Corporation (BLCO – Research Report) yesterday and set a ...

Comfort was the name of the game when OT spoke with contact lens manufacturers and suppliers about recent trends and launches ...

With Bausch + Lomb ULTRA ONE DAY contact lenses, eye care professionals can offer a solution that stands up to real-life ...

H.C. Wainwright analyst Yi Chen reiterated a Buy rating on Bausch + Lomb Corporation (BLCO ... It holds portfolio of more than 400 products includes contact lenses, lens care products, eye ...

Good morning and welcome to Bausch + Lomb’s Third Quarter 2024 Earnings Call. [Operator Instructions] Please note this event ...

Bausch + Lomb scaled up its revenue guidance for the year after swinging to a profit in the latest quarter on the back of sales growth in each of its business segments.

It isn't known whether Bausch + Lomb and/or Goldman is in contact with either Blackstone or TPG. According to the FT, several private equity funds mulling offers have dropped out of the race.

Shares of contact lens supplier Bausch + Lomb (BLCO) are surging in today ... a company specializing in surgical eye care solutions. How Much Will TPG and BX Be Willing to Pay for BLCO?